Suppr超能文献

肾病综合征中激肽形成的机制及意义

Mechanism and significance of kinin formation in nephrotic syndrome.

作者信息

Nakamura K, Kazama M, Morioka M, Tahara C, Abe T

出版信息

Adv Exp Med Biol. 1986;198 Pt B:253-62. doi: 10.1007/978-1-4757-0154-8_31.

Abstract

There were few reports demonstrating behavior of kinin and kininogen in the nephrotic syndrome. In this paper, coagulation factors related to contact activation, such as factor XII (FXII), factor XI (FXI), prekallikrein (PK), high molecular weight kininogen (HMWKG), and kinins were measured in 15 cases of nephrotic syndrome, and clinical significance of these results were discussed. Plasma FXII activity was markedly decreased in the onset and florid stages of nephrotic syndrome, and this decrease was not correlated with plasma albumin level, which suggested marked activation of this factor in these stages. However, the decrease of PK was slight at the above stages. Activations of contact factors were not parallely occurred with the marked consumption of FXII. Plasma kinin activity was not increased in the onset and critical stages of the nephrotic syndrome but increased in the convalescent and chronic stages, while HMWK level was maintained higher than normal throughout the course. Plasma angiotensin-converting enzyme (kininase II) activity was increased in the early stage and decreased lower than normal during the course of the disease. It was concluded that kinin formation in the nephrotic syndrome was not due to the activation of intrinsic coagulation system but due to release of kinin from low molecular weight kininogen. This increased level of kinin activity in convalescent and chronic stage may be related to the healing process during the course of this syndrome. Low kinin activity in the early stage of this disease might be also explained by increased kininase II activity.

摘要

关于激肽和激肽原在肾病综合征中的表现,相关报道较少。本文检测了15例肾病综合征患者体内与接触激活相关的凝血因子,如因子XII(FXII)、因子XI(FXI)、前激肽释放酶(PK)、高分子量激肽原(HMWKG)以及激肽,并探讨了这些结果的临床意义。肾病综合征发病期和急性期血浆FXII活性显著降低,且这种降低与血浆白蛋白水平无关,提示在这些阶段该因子被显著激活。然而,上述阶段PK的降低幅度较小。接触因子的激活与FXII的大量消耗并非平行发生。肾病综合征发病期和危象期血浆激肽活性未升高,但恢复期和慢性期升高,而HMWK水平在整个病程中均维持高于正常。血浆血管紧张素转换酶(激肽酶II)活性在疾病早期升高,病程中降低至低于正常水平。结论是,肾病综合征中激肽的形成并非由于内源性凝血系统的激活,而是由于低分子量激肽原释放激肽所致。恢复期和慢性期激肽活性升高可能与该综合征病程中的愈合过程有关。疾病早期激肽活性低也可能是由于激肽酶II活性增加所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验